The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 9 August 2005, www.theannals.com, DOI 10.1345/aph.1E661.
The Annals of Pharmacotherapy: Vol. 39, No. 10, pp. 1606-1609. DOI 10.1345/aph.1E661
© 2005 Harvey Whitney Books Company.
This Article
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schoeffler, J M.
Right arrow Articles by Gresham, D. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schoeffler, J M.
Right arrow Articles by Gresham, D. G

DIABETES

70/30 Insulin Algorithm Versus Sliding Scale Insulin

J Megan Schoeffler, PharmD1, Dennis AK Rice, PharmD BCPS2, and Douglas G Gresham, MD3

1 Resident, Pharmacy Practice, St. Joseph's/Candler Health System, Savannah, GA
2 Clinical Coordinator, St. Joseph's/Candler Health System
3 Endocrinologist, Savannah

Reprints: Dr. Rice, St. Joseph's/Candler Health System, 11705 Mercy Blvd., Savannah, GA 31419-1791, fax 912/819-8338, riced{at}sjchs.org

BACKGROUND: The medical literature supports the fact that sliding scale dosing of insulin is an ineffective means to control blood glucose concentrations. Despite this, many clinicians still use sliding scale insulin (SSI) regimens. A better tool for controlling hyperglycemia is clearly needed.

OBJECTIVE: To compare the efficacy of an algorithm using 70/30 insulin with traditional SSI dosing for glycemic control in hospitalized patients with type 2 diabetes.

METHODS: A prospective, cohort, comparative trial was conducted at a 644-bed, 2-hospital, regional referral health system. Patients were screened for enrollment based on orders received in the pharmacy for sliding scale dosing of insulin. Patients were treated either following an algorithm using 70/30 insulin twice daily or traditional SSI dosing as written by the prescribing physician.

RESULTS: Twenty patients with type 2 diabetes were involved in this pilot trial: 10 were treated with the 70/30 insulin algorithm and 10 received a physician-determined traditional SSI regimen. Patients treated based on the 70/30 insulin algorithm achieved better glycemic control (p = 0.042). No difference between the groups was detected in the average number of insulin units administered, insulin injections, or days patients spent on their respective insulin regimens.

CONCLUSIONS: Glycemic control with the 70/30 insulin algorithm was superior to traditional SSI dosing.

Key Words: algorithm: insulin sliding scale, 70/30

Published Online, August 9, 2005. www.theannals.com, DOI 10.1345/aph.1E661


This article has been cited by other articles:


Home page
Diabetes CareHome page
A. E. Kitabchi and E. Nyenwe
Sliding-Scale Insulin: More evidence needed before final exit?
Diabetes Care, September 1, 2007; 30(9): 2409 - 2410.
[Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 2005 by Harvey Whitney Books Company.